Part 1: Public Health Response to the Coronavirus

Cities are shuttered, flights are suspended, and cruise ships are in quarantine. The World Health Organization has recently declared the outbreak of the 2019 novel coronavirus a global health emergency. With more than 43,000 cases confirmed in China and more than 1000 deaths worldwide, many are seeking information on transmission routes and prevention methods as travel restrictions and infection rates increase around the world.

• Guest Christopher Mores, Professor and Program Director, Global Health Epidemiology and Disease Control, MPH Program, George Washington University School of Public Health
• Moderator Rick Berke, Co-Founder and Executive Editor, STAT 

 Part 2: Genomics and the Future of Medicine

We are living in the genomic era, and yet most people have not seen any direct benefit to their own health. But that might begin to change as a number of trends unfold, including the availability of more—and more diverse—data. Furthermore, technological innovations that include single-cell analysis, synthetic genomics, and gene editing could also truly revolutionize the care we receive as costs decline declining costs and higher-quality sequencing becomes available. What are the possible applications in healthcare in addition to those seen in research? What will this all add up to for the health of populations around the world—and when can we truly benefit in the age of genomics?

• Moderator Rick Berke, Co-Founder and Executive Editor, STAT
• Speaker Phil Febbo, Chief Medical Officer, Illumina
• Speaker Anamika Mehta, Patient Wellness Manager, Novomed
• Speaker Rakesh Suri, CEO, Cleveland Clinic Abu Dhabi